Cargando…

Annual costs among patients with major depressive disorder and the impact of key clinical events

BACKGROUND: The economic burden of major depressive disorder (MDD) is substantial and increasing; however, the impact of key clinical events (eg, hospitalization, suicide attempt/ideation, and treatment changes) on health care resource use and costs are less established. OBJECTIVE: To evaluate the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cutler, Andrew J, Keyloun, Katelyn R, Higa, Sara, Park, Julie, Bonafede, Machaon, Gillard, Patrick, Jain, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372988/ https://www.ncbi.nlm.nih.gov/pubmed/36427344 http://dx.doi.org/10.18553/jmcp.2022.28.12.1335

Ejemplares similares

Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database Analysis
por: Jain, Rakesh, et al.
Publicado: (2022)

Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
por: Keyloun, Katelyn R., et al.
Publicado: (2017)

Health Care Costs and Thromboembolic Events in Hydroxyurea-Treated Patients with Polycythemia Vera
por: Parasuraman, Shreekant V., et al.
Publicado: (2018)

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
por: Polsky, Daniel, et al.
Publicado: (2012)

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
por: Johnson, Barbara H, et al.
Publicado: (2016)

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis
por: Bonafede, Machaon, et al.
Publicado: (2021)

Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder
por: Ta, Jamie T, et al.
Publicado: (2021)

The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021)

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
por: Bonafede, Machaon, et al.
Publicado: (2014)

Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study
por: Bonafede, Machaon, et al.
Publicado: (2016)

Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021)

Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data
por: Gharaibeh, Mahdi, et al.
Publicado: (2020)

Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis
por: Bonafede, Machaon, et al.
Publicado: (2020)

The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections
por: Baradaran, Sarah, et al.
Publicado: (2018)

Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure
por: Bonafede, Machaon, et al.
Publicado: (2018)

456. Dalbavancin, a Long-Acting Lipoglycopeptide Antimicrobial Agent, Reduces Length of Stay and Improves Patient Work Productivity in a Hospital Critical Pathway for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)—the ENHANCE ABSSSI Trial
por: McCarthy, Matthew W, et al.
Publicado: (2019)

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives
por: Miller, Jeffrey D., et al.
Publicado: (2015)

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
por: Bonafede, Machaon M, et al.
Publicado: (2013)

Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
por: Johnson, Barbara H., et al.
Publicado: (2015)

Place of care and costs associated with acute episodes and remission in schizophrenia
por: McIntyre, Roger S, et al.
Publicado: (2023)

Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
por: McCarthy, Matthew W., et al.
Publicado: (2019)

Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
por: Fox, Robert J., et al.
Publicado: (2022)

Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs
por: Bonafede, Machaon M, et al.
Publicado: (2014)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives
por: Miller, Jeffrey D, et al.
Publicado: (2015)

Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data
por: Beyrer, Julie, et al.
Publicado: (2021)

Script-driven imagery of socially salient autobiographical memories in major depressive disorder
por: Gillard, Julia, et al.
Publicado: (2023)

Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
por: Paranagama, Dilan, et al.
Publicado: (2018)

Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis
por: Marshall, Alexander, et al.
Publicado: (2019)

Pathway with single‐dose long‐acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections
por: Talan, David A., et al.
Publicado: (2021)

Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study
por: Pawaskar, Manjiri, et al.
Publicado: (2013)

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population
por: Bonafede, Machaon M, et al.
Publicado: (2015)

The burden of cystic fibrosis in the Medicaid population
por: Hassan, Mariam, et al.
Publicado: (2018)

Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis
por: Jain, Rakesh, et al.
Publicado: (2022)

Identification of Key Modules and Genes Associated with Major Depressive Disorder in Adolescents
por: Zhao, Bao, et al.
Publicado: (2022)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
por: Mencacci, Claudio, et al.
Publicado: (2013)

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting
por: Bonafede, Machaon, et al.
Publicado: (2013)

Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
por: Soliman, Ahmed M., et al.
Publicado: (2018)

Care Among Migraine Patients in a Commercially Insured Population
por: Bonafede, Machaon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_shkn2s86m75ggh15lt9fgloap9